Skip to main content
. 2018 Aug 24;7(8):64. doi: 10.1038/s41389-018-0075-1

Fig. 6. shRNA knockdown of PTPIP51 in SK-BR3 cells.

Fig. 6

Immunoblots of PTPIP51, pMAPK, and pAkt of shRNA knockdown of PTPIP51 in SK-BR3 cells treated with 5 µM Gefitinib, 5 µM Lapatinib, 200 nM Neratinib, or 10 µM Mubritinib for 24 h (a). Evaluation of pMAPK immunoblots (b). Evaluation of pAkt immunoblots (c). Evaluation of PTPIP51 protein immunoblots (d). The immunoblots were normalized to the β-Actin level